676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of germline genetic mutations in patients with pancreatic cancer
    Journal Article

    Salo-Mullen, E. E.; O'Reilly, E. M.; Kelsen, D. P.; Ashraf, A. M.; Lowery, M. A.; Yu, K. H.; Reidy, D. L.; Epstein, A. S.; Lincoln, A.; Saldia, A.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility
    Journal Article

    Robson, M. E.; Bradbury, A. R.; Arun, B.; Domchek, S. M.; Ford, J. M.; Hampel, H. L.; Lipkin, S. M.; Syngal, S.; Wollins, D. S.; Lindor, N. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Breast cancer: Oophorectomy for BRCA1 ER-negative disease - An open debate
    Journal Article

    Kauff, N.; Robson, M.
    Nature Reviews Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 2 study (2-stage, 2-cohort) of the oral PARP inhibitor talazoparib (BMN 673) in patients with germline BRCA mutation and locally advanced and/or metastatic breast cancer (ABRAZO)
    Meeting Abstract

    Turner, N. C.; Balmana, J.; Fasching, P. A.; Hurvitz, S. A.; Telli, M. L.; Visco, F.; Wardley, A. M.; Zhang, C.; Lokker, N. A.; Lounsbury, D. L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study
    Meeting Abstract

    Shu, C. A.; Pike, M. C.; Jotwani, A. R.; Friebel, T. M.; Soslow, R. A.; Levine, D. A.; Robson, M. E.; Konner, J. A.; Blum, J. L.; Neuhausen, S. L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees
    Meeting Abstract

    Seidman, A. D.; Pilewskie, M. L.; Robson, M. E.; Kelvin, J. F.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Fu, J.; Keesing, J.; Caroline, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 2, 2-stage, 2-cohort study of the oral PARP inhibitor BMN 673 in patients with germline BRCA mutation and locally advanced and/or metastatic breast cancer (ABRAZO study)
    Meeting Abstract

    Turner, N. C.; Balmana, J.; Domchek, S. M.; Visco, F.; Zhang, C.; Lokker, N. A.; Lounsbury, D. L.; Robson, M. E.
    Cancer Research (2015)

    Fulltext@MSK | Save